This company listing is no longer active
ASLAN Pharmaceuticals 대차 대조표 상태
재무 상태 기준 확인 0/6
ASLAN Pharmaceuticals has a total shareholder equity of $-18.0M and total debt of $26.5M, which brings its debt-to-equity ratio to -147.6%. Its total assets and total liabilities are $21.0M and $39.0M respectively.
주요 정보
-147.6%
부채 비율
US$26.52m
부채
| 이자 보상 비율 | n/a |
| 현금 | US$18.40m |
| 주식 | -US$17.96m |
| 총 부채 | US$38.95m |
| 총 자산 | US$20.99m |
재무 상태 분석
단기부채: ASLN has negative shareholder equity, which is a more serious situation than short term assets not covering short term liabilities.
장기 부채: ASLN has negative shareholder equity, which is a more serious situation than short term assets not covering long term liabilities.
부채 대 자본 내역 및 분석
부채 수준: ASLN has negative shareholder equity, which is a more serious situation than a high debt level.
부채 감소: ASLN's has negative shareholder equity, so we do not need to check if its debt has reduced over time.
대차 대조표
현금 런웨이 분석
과거에 평균적으로 적자를 기록했던 기업의 경우, 최소 1년 이상의 현금 유동성을 보유하고 있는지 평가합니다.
안정적인 현금 활주로: ASLN has less than a year of cash runway based on its current free cash flow.
예측 현금 활주로: ASLN has less than a year of cash runway if free cash flow continues to grow at historical rates of 4.9% each year.